Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (06901) of the EORTC Leukemia Cooperative Group

Authors
Publication date
1 January 1996
Publisher

Abstract

Item does not contain fulltex

    Similar works

    Full text

    thumbnail-image

    Available Versions

    NARCIS

    redirect
    Last time updated on 03/09/2017

    Radboud Repository

    redirect
    oaioai:repository.ubn.ru.nl:2066/...
    Last time updated on 06/09/2013

    Radboud Repository

    redirect
    oaioai:repository.ubn.ru.nl:2066/...
    Last time updated on 11/04/2018

    NARCIS

    redirect
    Last time updated on 19/04/2018